...
首页> 外文期刊>Scientific reports. >Impact of maternal characteristics on human milk oligosaccharide composition over the first 4 months of lactation in a cohort of healthy European mothers
【24h】

Impact of maternal characteristics on human milk oligosaccharide composition over the first 4 months of lactation in a cohort of healthy European mothers

机译:在健康欧洲母亲队列的前4个月内母乳寡糖组合物对人乳寡糖组成的影响

获取原文
           

摘要

Human milk oligosaccharide (HMO) composition varies among lactating mothers and changes during the course of lactation period. Interindividual variation is largely driven by fucosyltransferase (FUT2 and FUT3) polymorphisms resulting in 4 distinct milk groups. Little is known regarding whether maternal physiological status contributes to HMO variability. We characterized the trajectories of 20 major HMOs and explored whether maternal pre-pregnancy body mass index (ppBMI), mode of delivery, or parity may affect milk HMO composition. Using longitudinal breastmilk samples from healthy mothers (n?=?290) across 7 European countries, we characterized HMO composion and employed mixed linear models to explore associations of maternal characteristics with individual HMOs. We observed HMO-specific temporal trajectories and milk group dependencies. We observed relatively small but significant differences in HMO concentrations based on maternal ppBMI, mode of delivery and parity. Our findings suggest that HMO composition to be regulated time-dependently by an enzyme as well as substrate availability and that ppBMI, mode of delivery, and parity may influence maternal physiology to affect glycosylation marginally within the initital period of lactation. Our observational study is the largest European standardized and longitudinal (up to 4 months) milk collection study assessing HMO concentrations and basic maternal characteristics. Time of lactation and milk groups had the biggest impact on HMO variation. Future studies need to elucidate these observations and assess the physiological significance for the breastfed infant.
机译:人乳寡糖(HMO)组成在哺乳期母亲和哺乳期过程中的变化中变化。细分变化主要由岩藻糖基转移酶(Fut2和Fut3)多态性导致4种不同的牛奶组。关于孕产妇的生理状态是否有助于变异性的少数人少。我们的特征在于20个主要汉摩源的轨迹,并探讨了孕产妇前妊娠体质量指数(PPBMI),递送方式,或平等可能会影响牛奶HMO组成。在7个欧洲国家使用来自健康母亲的纵向母乳样品(n?= 290),我们表征了HMO粉彩和使用混合线性模型,以探索母体特性与个体HMO的关联。我们观察了HMO特定的时间轨迹和牛奶组依赖性。我们观察到基于母体PPBMI,交付方式和平价模式的HMO浓度相对较小但显着差异。我们的研究结果表明,HMO组合物通过酶以及基质可用性和基板可用性和PPBMI,递送方式和奇偶校验可能影响母体生理,以在泌乳的初步期内略微影响糖基化。我们的观察研究是最大的欧洲标准化和纵向(最多4个月)牛奶收集研究,评估HMO浓度和基本母体特征。哺乳期和牛奶组的时间对HMO变异产生了最大的影响。未来的研究需要阐明这些观察结果,并评估母乳喂养的生理意义。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号